Cardiff Oncology, Inc. (CRDF)
NASDAQ·Healthcare·Biotechnology
$1.69
-2.03%
Mkt Cap $117.59M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.69
-2.03%
Mkt Cap $117.59M
Buy
2
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —